0000849146-24-000007.txt : 20240103
0000849146-24-000007.hdr.sgml : 20240103
20240103162306
ACCESSION NUMBER: 0000849146-24-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cunningham Kristen
CENTRAL INDEX KEY: 0001938042
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35647
FILM NUMBER: 24506841
MAIL ADDRESS:
STREET 1: 3300 N. TRIUMPH BLVD, SUITE 700
CITY: LEHI
STATE: UT
ZIP: 84043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lifevantage Corp
CENTRAL INDEX KEY: 0000849146
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 900224471
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 3300 TRIUMPH BLVD
STREET 2: SUITE 700
CITY: LEHI
STATE: UT
ZIP: 84043
BUSINESS PHONE: 801-432-9000
MAIL ADDRESS:
STREET 1: 3300 TRIUMPH BLVD
STREET 2: SUITE 700
CITY: LEHI
STATE: UT
ZIP: 84043
FORMER COMPANY:
FORMER CONFORMED NAME: LIFELINE THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20041019
FORMER COMPANY:
FORMER CONFORMED NAME: YAAK RIVER RESOURCES INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: ANDRAPLEX CORP
DATE OF NAME CHANGE: 19920406
4
1
wk-form4_1704316967.xml
FORM 4
X0508
4
2024-01-01
0
0000849146
Lifevantage Corp
LFVN
0001938042
Cunningham Kristen
3300 TRIUMPH BLVD, SUITE 700
LEHI
UT
84043
0
1
0
0
Chief Sales Officer
0
Common Stock
2024-01-01
4
M
0
3000
0
A
92768
D
Common Stock
2024-01-01
4
F
0
1827
6
D
90941
D
Performance Restricted Stock Units
2024-01-01
4
M
0
3000
0
D
Common Stock
3000
18004
D
On August 18, 2022, the reporting person was granted PSUs which vest only to the extent specified financial performance criteria are achieved and subject to the reporting person's continued service with the Issuer, as follows: (i) 1/3 of the earned award vested on the first anniversary of the grant date and (ii) an additional 1/12 of the earned award will vest on the first day of each calendar quarter thereafter. The reporting person initially reported the number of shares that were eligible to be earned at target-level performance achievement. The performance criteria were achieved at a level above target; accordingly, the reporting person is eligible to earn 133.13% of the target number of units. The actual number of shares that vested on the reported transaction date was 133.13% of the at-target number of shares subject to vesting on that date and the number of PSUs beneficially owned following the reported transaction has been updated to reflect the new target number of units.
These shares were withheld to satisfy tax withholding obligations in connection with the vesting of stock unit awards granted to the reporting person on August 12, 2021 and PSU awards and stock unit awards granted to the reporting person on August 18, 2022.
Performance Restricted Stock Units ("PSUs") convert into common stock on a one-for-one basis.
Alissa Neufeld, Power of Attorney for Kristen Cunningham
2024-01-03